Richard K. Desser

1.5k total citations
30 papers, 995 citations indexed

About

Richard K. Desser is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Richard K. Desser has authored 30 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Richard K. Desser's work include Lung Cancer Research Studies (8 papers), Breast Cancer Treatment Studies (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Richard K. Desser is often cited by papers focused on Lung Cancer Research Studies (8 papers), Breast Cancer Treatment Studies (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Richard K. Desser collaborates with scholars based in United States. Richard K. Desser's co-authors include Jacob D. Bitran, John E. Ultmann, Daniel Deykin, Mark Kozloff, Charles M. Shapiro, Harvey M. Golomb, Warren H. Evans, Emma Shelton, Michael G. Mage and S. Himmelhoch and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Richard K. Desser

29 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard K. Desser United States 19 428 354 218 167 141 30 995
C.G. Alexopoulos Greece 15 421 1.0× 219 0.6× 106 0.5× 123 0.7× 131 0.9× 34 789
Kenneth B. Olson United States 16 461 1.1× 514 1.5× 165 0.8× 197 1.2× 51 0.4× 42 1.2k
Joel B. Levine United States 15 290 0.7× 172 0.5× 264 1.2× 249 1.5× 92 0.7× 31 1.1k
P. Dodion Belgium 20 446 1.0× 204 0.6× 120 0.6× 101 0.6× 106 0.8× 72 1.1k
E H Cooper United Kingdom 20 523 1.2× 194 0.5× 109 0.5× 222 1.3× 59 0.4× 39 1.2k
N. I. Nissen Denmark 19 373 0.9× 157 0.4× 196 0.9× 126 0.8× 30 0.2× 58 1.0k
Νicolas Tsavaris Greece 22 999 2.3× 495 1.4× 161 0.7× 304 1.8× 149 1.1× 87 1.7k
U. Bruntsch Germany 16 319 0.7× 173 0.5× 107 0.5× 198 1.2× 61 0.4× 55 834
P. Buytaert Belgium 17 260 0.6× 128 0.4× 261 1.2× 217 1.3× 203 1.4× 47 1.2k
U. Fabry Germany 18 185 0.4× 219 0.6× 302 1.4× 97 0.6× 56 0.4× 27 916

Countries citing papers authored by Richard K. Desser

Since Specialization
Citations

This map shows the geographic impact of Richard K. Desser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard K. Desser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard K. Desser more than expected).

Fields of papers citing papers by Richard K. Desser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard K. Desser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard K. Desser. The network helps show where Richard K. Desser may publish in the future.

Co-authorship network of co-authors of Richard K. Desser

This figure shows the co-authorship network connecting the top 25 collaborators of Richard K. Desser. A scholar is included among the top collaborators of Richard K. Desser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard K. Desser. Richard K. Desser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bitran, Jacob D., Mark Kozloff, & Richard K. Desser. (1990). Platinol (CDDP) and Continuous Intravenous Infusion 5-Fluorouracil in Refractory Stage IV Breast Cancer: A Phase II Study. Cancer Investigation. 8(3-4). 335–338. 16 indexed citations
2.
Williams, S F, et al.. (1989). High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer.. Journal of Clinical Oncology. 7(12). 1824–1830. 88 indexed citations
3.
Golomb, Harvey M., Dennis E. Hallahan, Richard K. Desser, et al.. (1989). Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 17(4). 761–766. 13 indexed citations
4.
Hallahan, Dennis E., Howard J. Halpern, A. Awan, et al.. (1989). Breast conserving surgery and definitive irradiation for early stage breast cancer. International Journal of Radiation Oncology*Biology*Physics. 17(6). 1211–1216. 17 indexed citations
5.
Farah, Roula, J E Ultmann, Melvin L. Griem, et al.. (1988). Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease.. Journal of Clinical Oncology. 6(6). 1047–1052. 33 indexed citations
6.
Greenburg, A. Gerson, Jacob D. Bitran, Philip C. Hoffman, et al.. (1986). A 10-year experience with combined modality therapy for stage III small cell lung carcinoma. Cancer. 58(10). 2177–2184. 19 indexed citations
7.
Vogelzang, N., et al.. (1986). Treatment of soft tissue sarcoma with fibroblast interferon (beta-interferon): an American Cancer Society/Illinois Cancer Council Study.. PubMed. 70(2). 293–4. 5 indexed citations
8.
Bitran, Jacob D., Harvey M. Golomb, Philip G. Hoffman, et al.. (1984). Combined modality therapy for stage IIIMO non-small cell lung cancer. A five-year experience. Cancer. 54(1). 5–12. 20 indexed citations
9.
Bitran, Jacob D., et al.. (1983). Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy. Cancer. 51(3). 381–384. 21 indexed citations
10.
Shapiro, Charles M., Jacob D. Bitran, Richard K. Desser, et al.. (1982). Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast. Journal of Surgical Oncology. 19(2). 119–121. 23 indexed citations
11.
Swerdlow, Martin, et al.. (1980). Postirradiation Malignant Fibrous Histiocytoma of the Lung: Demonstration of Alpharantitrypsin-like Material in Neoplastic Cells. American Journal of Clinical Pathology. 74(6). 820–826. 39 indexed citations
12.
Jd, Bitran, et al.. (1980). Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).. PubMed. 63(11-12). 2049–51. 61 indexed citations
13.
Cooksey, Judith A., Jacob D. Bitran, Richard K. Desser, et al.. (1979). Small-cell carcinoma of the lung: the prognostic significance of stage on survival. European Journal of Cancer (1965). 15(6). 859–865. 13 indexed citations
14.
Bitran, Jacob D., Richard K. Desser, Thomas Demeester, & Harvey M. Golomb. (1978). Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 240(25). 2743–6. 29 indexed citations
15.
Bitran, Jacob D., et al.. (1976). Survival of patients with lung cancer treated with vincristine and actinomycin D.An unsuccessful trial. Cancer. 37(4). 1669–1672. 1 indexed citations
16.
Sweet, Donald L., et al.. (1975). CHEMOTHERAPY OF ADVANCED HISTIOCYTIC LYMPHOMAS. The Lancet. 305(7916). 1136–1136.
17.
Desser, Richard K., Edgar M. Moran, & John E. Ultmann. (1973). Staging of Hodgkin’s Disease and Lymphoma: Diagnostic Procedures Including Staging Laparotomy and Splenectomy. Medical Clinics of North America. 57(2). 479–498. 30 indexed citations
18.
Desser, Richard K. & John E. Ultmann. (1972). Risk of Severe Infection in Patients with Hodgkin's Disease or Lymphoma After Diagnostic Laparotomy and Splenectomy. Annals of Internal Medicine. 77(1). 143–146. 77 indexed citations
19.
Desser, Richard K., et al.. (1972). Guinea pig heterophil and eosinophil peroxidase. Archives of Biochemistry and Biophysics. 148(2). 452–465. 122 indexed citations
20.
Deykin, Daniel & Richard K. Desser. (1968). The incorporation of acetate and palmitate into lipids by human platelets. Journal of Clinical Investigation. 47(7). 1590–1602. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.G. Alexopoulos Breakdown of academic impact, for papers by Kenneth B. Olson Breakdown of academic impact, for papers by Joel B. Levine Breakdown of academic impact, for papers by P. Dodion Breakdown of academic impact, for papers by E H Cooper Breakdown of academic impact, for papers by N. I. Nissen Breakdown of academic impact, for papers by Νicolas Tsavaris Breakdown of academic impact, for papers by U. Bruntsch Breakdown of academic impact, for papers by P. Buytaert Breakdown of academic impact, for papers by U. Fabry
Rankless by CCL
2026